Rituximab is a monoclonal antibody used to treat certain B-cell blood cancers and autoimmune diseases. It is administered by intravenous infusion, either alone or with other treatments, under specialist supervision and careful monitoring.
| Generic Name | Rituximab |
| Strength | 500 mg |
| Manufacturer | Eli Lilly and Company |
| Packing | 1 Vial |
| Prescribed For | Non-Hodgkin’s lymphoma and chronic lymphocytic leukemia |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Rituximab attaches to a protein called CD20 found on the surface of B lymphocytes. This marks the targeted B cells for destruction by the immune system. Removing abnormal or overactive B cells helps treat certain blood cancers and autoimmune conditions.